Getein Biotech (603387)

Getein Biotech (603387)

$ 10

Trading Risk Analysis

English Version

Date : 1 Jan 2021


Getein Biotech, Inc. is a China-based company principally engaged in the research and development, production and sales of in vitro diagnostic products. The Company’s main products include point-of-care testing (POCT) in vitro diagnostic reagents and ancillary equipment. The Company is also engaged in the production and sales of biochemical latex in vitro diagnostic reagents. The Company mainly operates its businesses in East China, Central China, North China and Southwest region.


There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

You may also like…

Close Bitnami banner